What percentage of patients develop heart block after Transcatheter Aortic Valve Replacement (TAVR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Approximately 15% of patients develop heart block after Transcatheter Aortic Valve Replacement (TAVR), with permanent pacemaker implantation required in a significant portion of these cases. The risk of heart block after TAVR is influenced by several factors, including the type of valve used, pre-existing conduction abnormalities, and anatomical considerations.

  • The type of valve used plays a significant role, with self-expanding valves like CoreValve having higher rates of heart block compared to balloon-expandable valves like SAPIEN 1.
  • Patients with pre-existing right bundle branch block (RBBB) are at particularly high risk, with rates of complete heart block approaching 24% 1.
  • The mechanism involves mechanical trauma to the conduction system, as the aortic valve sits in close proximity to the bundle of His and left bundle branch.
  • Heart block typically develops within 24-48 hours post-procedure, though delayed conduction disturbances can occur up to 7 days later 1.
  • This risk necessitates careful ECG monitoring after TAVR, with some centers implementing extended monitoring protocols for high-risk patients.
  • The majority of conduction disturbances occur early, which is why close monitoring in the immediate post-procedural period is essential.
  • A recent study found that patients who did not develop pacing-induced Wenckebach AV block have a very low need for permanent pacing, highlighting the importance of individualized monitoring and management strategies 1.

From the Research

Incidence of Heart Block after TAVR

  • The incidence of heart block after Transcatheter Aortic Valve Replacement (TAVR) varies, with studies reporting different percentages of patients developing this condition.
  • According to a study published in 2017 2, approximately 9% of patients (54 out of 578) required permanent pacemakers for high-degree atrioventricular block (HD-AVB) after TAVR.
  • Another study published in 2021 3 reported an incidence of 16.1% (153 out of 953 patients) of high-grade atrioventricular block (HAVB) after TAVR.
  • A more recent study published in 2022 4 found that 29.4% (10 out of 34 patients) with new-onset left bundle branch block (LBBB) after TAVR developed clinically significant heart block.

Predictors of Heart Block after TAVR

  • Several studies have identified predictors of heart block after TAVR, including:
  • Age 2
  • Right bundle branch block 2
  • Atrial fibrillation 2, 4
  • Self-expanding valves 2, 3
  • New left bundle branch block 3, 4
  • Pre-existing first-degree heart block 4
  • STS score 4
  • These predictors can help identify patients at high risk of developing heart block after TAVR and inform management strategies.

Management of Heart Block after TAVR

  • The management of heart block after TAVR typically involves the implantation of a permanent pacemaker.
  • According to a study published in 2021 5, the need for permanent pacemaker implantation for post-TAVR high-degree atrioventricular block (HAVB) has persisted despite advances in TAVR technology and techniques.
  • The study also notes that most HAVB occurs within 48 hours of the procedure, but there is a growing number of patients developing HAVB after initial hospitalization for TAVR due to early discharge trends.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.